Healthcare organizations are increasingly seeking scalable solutions that improve access, boost efficiency and support workforce well-being. At Philadelphia-based Penn Medicine, two such initiatives ...

Holly Fernandez Lynch has become a key voice in observing, understanding, and criticizing the Food and Drug Administration. A bioethicist and lawyer, she studies the process of drug development ...

What happens when an artist steps into the world of empirical science? A residency at the Penn Center for Neuroaesthetics ...

Morris, Director of the Division of Biostatistics at the Perelman School of Medicine wrote on X, after outlining the flaws in one of Geier's papers. ⓘ IFLScience is not responsible for content ...

“This is a huge mistake,” said Dr. Ezekiel Emanuel, the co-director of the Healthcare Transformation Institute at the University of Pennsylvania’s Perelman School of Medicine. We are having ...

and clinical investigators at the Perelman School of Medicine at the University of Pennsylvania. The study is evaluating Inovio's DNA-encoded monoclonal antibodies (DMAb) technology as a treatment ...

Mike Segar/Reuters Lp(a)-lowering “is a huge new frontier in cardiovascular medicine,” said Dr. Daniel Rader, a preventive cardiologist at the University of Pennsylvania’s Perelman School of ...

A new study from the Perelman School of Medicine at the University of Pennsylvania has found that the addition of anti-obesity medications is beneficial for people who do not lose weight with ...

Pointing to a positive example of AI at work, Tormey cited an account by Dr. David Fajgenbaum, a professor at the University of Pennsylvania Perelman School of Medicine and co-founder of research ...

“This is not ivory tower science that doesn’t affect you,” said Holly Fernandez Lynch, an associate professor of medical ethics at the University of Pennsylvania Perelman School of Medicine.